Literature DB >> 3556115

Expression of HLA antigens in paraffin sections of uveal melanomas.

M J Jager, D de Wolff-Rouendaal, A C Breebaart, D J Ruiter.   

Abstract

Expression of histocompatibility (HLA) antigens on tumor cells may influence the recognition of these tumor cells by the immune system. Immunological recognition may influence tumor growth and patient survival. Although HLA class I and II antigens are known to be present on several tissues in the eye, their presence on ocular tumors had not yet been demonstrated. We studied the expression of these antigens on paraffin preparations of uveal melanomas. Most tumors carried class I and beta 2m antigens on most of their cells while class II antigens were less often expressed. No association with tumor cell type or tumor size was observed. Further studies will be necessary to determine the relevance of different levels of antigen expression with regard to patient survival.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3556115     DOI: 10.1007/BF00166687

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  8 in total

Review 1.  Class II transplantation antigens: distribution in tissues and involvement in disease.

Authors:  U Forsum; K Claesson; E Hjelm; A Karlsson-Parra; L Klareskog; A Scheynius; U Tjernlund
Journal:  Scand J Immunol       Date:  1985-05       Impact factor: 3.487

2.  The expression of HLA-antigens in the human anterior uvea.

Authors:  M Bakker; A Kijlstra
Journal:  Curr Eye Res       Date:  1985-05       Impact factor: 2.424

Review 3.  The major histocompatibility complex--genetics and biology. (First of three parts).

Authors:  F H Bach; J J van Rood
Journal:  N Engl J Med       Date:  1976-10-07       Impact factor: 91.245

4.  Phenotypic dynamics of tumor progression in human malignant melanoma.

Authors:  E B Bröcker; L Suter; J Brüggen; D J Ruiter; E Macher; C Sorg
Journal:  Int J Cancer       Date:  1985-07-15       Impact factor: 7.396

5.  HLA-antigens in the human uvea.

Authors:  M Bakker; F C Grumet; T E Feltkamp; A Kijlstra
Journal:  Doc Ophthalmol       Date:  1986-01-15       Impact factor: 2.379

6.  Assessment of immunological techniques in the diagnosis and prognosis of ocular malignant melanoma.

Authors:  A J Cochran; W S Foulds; B E Damato; G E Trope; L Morrison; W R Lee
Journal:  Br J Ophthalmol       Date:  1985-03       Impact factor: 4.638

7.  Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens.

Authors:  D J Ruiter; W Bergman; K Welvaart; E Scheffer; W A van Vloten; C Russo; S Ferrone
Journal:  Cancer Res       Date:  1984-09       Impact factor: 12.701

8.  Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon.

Authors:  A N Houghton; T M Thomson; D Gross; H F Oettgen; L J Old
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

  8 in total
  3 in total

1.  HLA expression in a primary uveal melanoma, its cell line, and four of its metastases.

Authors:  D J Blom; L R Schurmans; I De Waard-Siebinga; D De Wolff-Rouendaal; J E Keunen; M J Jager
Journal:  Br J Ophthalmol       Date:  1997-11       Impact factor: 4.638

Review 2.  Uveal melanoma: estimating prognosis.

Authors:  Swathi Kaliki; Carol L Shields; Jerry A Shields
Journal:  Indian J Ophthalmol       Date:  2015-02       Impact factor: 1.848

Review 3.  HLA Expression in Uveal Melanoma: An Indicator of Malignancy and a Modifiable Immunological Target.

Authors:  Zahra Souri; Annemijn P A Wierenga; Arend Mulder; Aart G Jochemsen; Martine J Jager
Journal:  Cancers (Basel)       Date:  2019-08-07       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.